Doheny_UCLAStein_PMS.png
Doheny Eye Institute Announces Upcoming Presentations at ARVO 2023 Annual Meeting
April 21, 2023 09:05 ET | Doheny Eye Institute
PASADENA, Calif., April 21, 2023 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, announced that more than 30 of its scientists and...
Global Macular Degeneration Treatment Market
Global Macular Degeneration Treatment Market Report 2023: Major Players Include Novartis, Bausch Health Companies, Regenxbio, F Hoffmann-La Roche and Regeneron Pharmaceuticals
March 23, 2023 11:03 ET | Research and Markets
Dublin, March 23, 2023 (GLOBE NEWSWIRE) -- The "Macular Degeneration Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Global Retinal Disorder Treatment Market
Global Retinal Disorder Treatment Market Report 2023 to 2030: Increasing Prevalence of Target Diseases Drives Growth
March 14, 2023 12:18 ET | Research and Markets
Dublin, March 14, 2023 (GLOBE NEWSWIRE) -- The "Retinal Disorder Treatment Market Size, Share & Trends Analysis Report By Type (Macular Degeneration, Diabetic Retinopathy), By Dosage Form, By...
Global Fundus Camera Market
Fundus Camera Global Market Report 2023: Increasing Number of Product Launches by Key Players is Expected to Propel Growth
March 01, 2023 09:48 ET | Research and Markets
Dublin, March 01, 2023 (GLOBE NEWSWIRE) -- The "Fundus Camera Market, by Product Type, by Modality, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report...
Home OCT NOA Fluid Volume Trajectory
Clinical trials results demonstrate value of home OCT at international meetings
February 22, 2023 08:00 ET | Notal Vision
Manassas, VA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Notal Vision, Inc. reported today that the latest data on its investigational home-based optical coherence tomography (OCT) and how the service can be...
Kinarus-Logo_RGB.jpg
Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update
February 21, 2023 01:00 ET | Kinarus Therapeutic Holding AG
KINFAST is evaluating KIN001 for reduction in severity and duration of Covid-19 symptomsKINFAST is actively enrolling in Germany/Switzerland Basel, Switzerland, 20 February 2023. Kinarus Therapeutics...
Age-Related Macular Degeneration (AMD) Market
Age-Related Macular Degeneration (AMD) Global Market Report 2022: Featuring F. Hoffman - La Roche, Bayer, Abbvie, GSK, Novartis, Regeneron Pharmaceuticals, Bausch Health & Alimera Sciences
January 24, 2023 04:48 ET | Research and Markets
Dublin, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The "Age-Related Macular Degeneration (AMD) Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis"...
Kinarus-Logo_RGB.jpg
Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan
January 17, 2023 01:00 ET | Kinarus Therapeutic Holding AG
 KIN001 reduced fibrotic damage of the lung in a preclinical fibrosis modelPotential as an effective oral therapy for Idiopathic Pulmonary Fibrosis (IPF)Phase 2 clinical trial in IPF patients in...
visiongain Logo.png
Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 10.74% by 2032: Visiongain Reports Ltd
January 09, 2023 09:00 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled Macular Degeneration (AMD) and Other Retinal Diseases Drugs 2022-2032. It includes profiles of Macular Degeneration (AMD) and Other Retinal Diseases...
22157.jpg
$156.3+ Billion Worldwide Eyewear Industry to 2031 - Increasing Cases of Deteriorating Eye Health Drives Growth
January 09, 2023 06:33 ET | Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "Eyewear Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and...